Doximity, Inc. (DOCS) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 150.36M USD | Liabilities, Current |
| Cash and equivalents | 273.60M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 177.57M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $150.36M | $273.60M | (m) | $177.57M | (m) | (m) |
| 2026-03-31 | (m) | $154.97M | $219.18M | (m) | $144.78M | (m) | (m) |
| 2025-12-31 | (m) | $149.85M | $64.84M | (m) | $156.59M | (m) | (m) |
| 2025-09-30 | (m) | $140.27M | $169.25M | (m) | $129.31M | (m) | (m) |
| 2025-06-30 | (m) | $159.91M | $137.26M | (m) | $141.66M | (m) | (m) |
| 2025-03-31 | (m) | $156.26M | $209.61M | (m) | $128.35M | (m) | (m) |
| 2024-12-31 | (m) | $115.88M | $165.27M | (m) | $137.50M | (m) | (m) |
| 2024-09-30 | (m) | $132.28M | $184.25M | (m) | $124.79M | (m) | (m) |
| 2024-06-30 | (m) | $135.28M | $111.44M | (m) | $120.91M | (m) | (m) |
| 2024-03-31 | (m) | $147.25M | $96.78M | (m) | $101.33M | (m) | (m) |
| 2023-12-31 | (m) | $104.76M | $123.09M | (m) | $97.58M | (m) | (m) |
| 2023-09-30 | (m) | $123.18M | $108.40M | (m) | $97.22M | (m) | (m) |
| 2023-06-30 | (m) | $132.69M | $306.73M | (m) | $92.92M | (m) | (m) |
| 2023-03-31 | (m) | $139.51M | $158.03M | (m) | $107.05M | (m) | (m) |
| 2022-12-31 | (m) | $105.88M | $136.45M | (m) | $74.86M | (m) | (m) |
| 2022-09-30 | (m) | $118.14M | $73.67M | (m) | $79.24M | (m) | (m) |
| 2022-06-30 | (m) | $120.75M | $110.09M | (m) | $76.02M | (m) | (m) |
| 2022-03-31 | (m) | $111.28M | $112.81M | (m) | $81.07M | (m) | (m) |
| 2021-12-31 | (m) | $91.71M | $85.08M | (m) | $69.82M | (m) | (m) |
| 2021-09-30 | (m) | $95.62M | $79.52M | (m) | $55.68M | (m) | (m) |
| 2021-06-30 | (m) | $100.18M | $594.32M | (m) | $45.99M | (m) | (m) |
| 2021-03-31 | (m) | $102.04M | $66.39M | (m) | $50.32M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.